Genius Earn Limited - Net Worth and Insider Trading

Genius Earn Limited Net Worth

The estimated net worth of Genius Earn Limited is at least $138 Million dollars as of 2024-09-22. Genius Earn Limited is the 2201 Interest of corporation controlled by you of China Biotech Services Holdings Ltd and owns about 529,500,546 shares of China Biotech Services Holdings Ltd (HKSE:08037) stock worth over $138 Million. Details can be seen in Genius Earn Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Genius Earn Limited has not made any transactions after 2022-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Genius Earn Limited

Genius Earn Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Genius Earn Limited owns 1 companies in total, including China Biotech Services Holdings Ltd (HKSE:08037) .

Click here to see the complete history of Genius Earn Limited’s form 4 insider trades.

Insider Ownership Summary of Genius Earn Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:08037	China Biotech Services Holdings Ltd	2022-12-30	2201 Interest of corporation controlled by you

Genius Earn Limited Latest Holdings Summary

Genius Earn Limited currently owns a total of 1 stock. Genius Earn Limited owns 529,500,546 shares of China Biotech Services Holdings Ltd (HKSE:08037) as of December 30, 2022, with a value of $138 Million.

Latest Holdings of Genius Earn Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:08037	China Biotech Services Holdings Ltd	2022-12-30	529,500,546	0.26	137,670,142

Holding Weightings of Genius Earn Limited

Genius Earn Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Genius Earn Limited has made a total of 2 transactions in China Biotech Services Holdings Ltd (HKSE:08037) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in China Biotech Services Holdings Ltd is the sale of 0 shares on December 30, 2022, which brought Genius Earn Limited around $0.

Insider Trading History of Genius Earn Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Genius Earn Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Genius Earn Limited Ownership Network

Ownership Network List of Genius Earn Limited

No Data

Ownership Network Relation of Genius Earn Limited

Genius Earn Limited Owned Company Details

What does China Biotech Services Holdings Ltd do?

Who are the key executives at China Biotech Services Holdings Ltd?

Genius Earn Limited is the 2201 Interest of corporation controlled by you of China Biotech Services Holdings Ltd. Other key executives at China Biotech Services Holdings Ltd include 2101 Beneficial owner Liu Xiaolin , 2101 Beneficial owner Genius Lead Limited , and 2201 Interest of corporation controlled by you Guoyuan International Holdings Limited .

China Biotech Services Holdings Ltd (HKSE:08037) Insider Trades Summary

Over the past 18 months, Genius Earn Limited made no insider transaction in China Biotech Services Holdings Ltd (HKSE:08037). Other recent insider transactions involving China Biotech Services Holdings Ltd (HKSE:08037) include a net purchase of 240,000 shares made by Liu Xiaolin ,

In summary, during the past 3 months, insiders sold 0 shares of China Biotech Services Holdings Ltd (HKSE:08037) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Biotech Services Holdings Ltd (HKSE:08037) were sold and 240,000 shares were bought by its insiders, resulting in a net purchase of 240,000 shares.

China Biotech Services Holdings Ltd (HKSE:08037)'s detailed insider trading history can be found in Insider Trading Tracker table.

China Biotech Services Holdings Ltd Insider Transactions

No Available Data

Genius Earn Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Genius Earn Limited. Currently GuruFocus does not have mailing address information for Genius Earn Limited.

Discussions on Genius Earn Limited

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.